Early Monitoring of Response (MORE) to Golimumab Therapy Based on Fecal Calprotectin and Trough Serum Levels in Patients With Ulcerative Colitis: A Multicenter Prospective Study
Early Monitoring of Response (MORE) to Golimumab Therapy Based on Fecal Calprotectin and Trough Serum Levels in Patients With Ulcerative Colitis: A Multicenter Prospective Study
Altmetric
Altmetric discovers Social Media mentions. Click the ‘See more details’ link for a full report.
Dimensions
Dimensions discovers Citations. Click the ‘details’ link for a full report.
Metrics Since Publication